Healthcare and Life Sciences

Not waiting for nature-positive standards, UK multinational GSK is taking action and a leadership role in the pharma and biotech sector. By Alastair Morton and Ellie Fallon.

Following his history-making turn as COVID vaccine development lead for Operation Warp Speed, Matthew Hepburn oversees pandemic preparedness at The White House Office of Science and Technology Policy.

As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which come from having new and different antibiotics. Francesca Scassellati Sforzolini, Healthcare & Life Sciences Lead, Europe, reports.

Anti-aging research is accelerating, with profound implications for society. By Ben Hirschler.

Venture philanthropy expert and public health advocate Olga Rudneva talks to us about helping Ukraine’s wounded become living symbols of a new country. By Maria Figueroa Küpçü and Carlton Wilkinson.

Brunswick’s Ben Hirschler describes taking part in a COVID-19 vaccine trial as part of the historic global effort to halt the disease.

The pharmaceutical industry is seizing the moment to both help lift society out of the pandemic and rebuild its own reputation. The clock is ticking. By Brunswick’s Ben Hirschler and Jeremy Ruch.

She entered the water hoping to regain her mobility. She became a record-breaking aquatic marathoner. By Craig Mullaney.

Adrian Gore, founder and CEO of Discovery Group, talks to Brunswick’s Marina Bidoli and Georgie Armstrong about working for the greater good and the power of positivity.

One state’s readiness could serve as a model for the nation and the world. “Coronavirus Slayer” K.K. Shailaja, Kerala’s Health Minister, talks to Brunswick’s Khozem Merchant.